Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The SP & TR patients.

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 07, 2023 2:51pm

179 Views

Post# 35435428

RE:RE:The SP & TR patients.

I think the patients could have been evaluated back in Dec. The results tallied sometime since then. The data you are looking at might still be from the Nov '22 Financial update. The more recent CR data is improved somewhat. So when will TLT apply for BTD then? My guess is they have done so recently, or are about to in the coming days/weeks...

<< Previous

Bullboard Posts

Next >>

Coppernico in Peru: Inaugural drilling on a promising opportunity